A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

Inclusion criteria

• Able and willing to provide a written informed consent
• Subjects requiring local anesthesia assisted sedation
• Male or female
• Meet the weight standard
• Conform to the ASA Physical Status Classification

Exclusion criteria

• Previous respiratory or pulmonary diseases
• Subjects who had received general anesthesia
• Subjects with a history of myocardial infarction or unstable angina pectoris
• Subjects with atrioventricular block or cardiac insufficiency
• Subjects with a history of ischemic stroke or transient ischemic attack
• Subjects with poor blood pressure control after medication
• Subjects with abnormal clotting function
• Subjects with a history of mental illness and a history of cognitive impairment epilepsy
• Subjects with a history or possibility of a difficult airway
• Subject with a history of substance abuse and drug abuse
• Abnormal values in the laboratory
• Allergic to a drug ingredient or component
• Pregnant or nursing women
• No birth control during the specified period of time
• Participated in clinical trials of other drugs (received experimental drugs)
• The inestigators determined that other conditions were inappropriate for participation in this clinical trial